Introduction
The ability of interferons (IFNs) to activate natural killer (NK) cells is an important property of these mediators. By inducing differentiation of pre-NK to active NK forms, enhancing the lytic potency of a single killer cell, and accelerating the recycling of NK' cells after lytic interaction with their targets ',3 IFNs serve factors playing a key role in the function of this lymphocyte population.
1,"
The spectrum of immunomodulatory action of IFNs, as well as their strong antiproliferative activity, has led to the use of IFN preparations in the therapy of oncological diseases. 5 (Fig. 2) . The action of the suggested inhibitor of IFN regulatory action on NK (n is the number of observations) activity was evaluated by adding it, at doses corresponding to those used for induced auto-IFNs, to a PBL suspension stimulated with auto-IFN, and incubating the mixture as described above for auto-IFNs.
After this procedure TRPs became equal to 6 + 5% (p < 0.05) for IFN--and to 9 + 7% (p < 0.05) for IFN-y. The difference was statistically significant for both these auto-IFNs (Fig. 2) 
